| Medical Supplies, Inc. | |
| 312 4th St Sw, Ste 3, Willmar, Minnesota 56201 | |
| (320) 231-3655 |
| Name | Medical Supplies, Inc. |
|---|---|
| Organization Name | Medical Supplies Inc. |
| Location | 312 4th St Sw, Ste 3, Willmar, Minnesota 56201 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (320) 231-3655 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
An outbreak of Dengue Haemorrhagic Fever (DHF) in Delhi, India has authorities concerned that they may be seeing the start of an epidemic.
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
Roche announced today that the US Food and Drug Administration has provided 510(k) clearance for the cobas Cdiff Test to detect Clostridium difficile (C. difficile) in stool specimens.
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
KalVista Pharmaceuticals, a research-led pharmaceutical company, today announced it has raised $33 million in a Series B financing to support its research and clinical development programs. KalVista will use the funds to advance its proprietary portfolio of plasma kallikrein inhibitors for treating diabetic macular edema (DME) and hereditary angioedema (HAE).
› Verified 2 days ago
| NPI Number | 1134268014 |
| Organization Name | MEDICAL SUPPLIES INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 312 4th St Sw, Suite 3, Willmar, MN 56201 |
| Phone Number | 320-231-3655 |
News Archive
An outbreak of Dengue Haemorrhagic Fever (DHF) in Delhi, India has authorities concerned that they may be seeing the start of an epidemic.
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
Roche announced today that the US Food and Drug Administration has provided 510(k) clearance for the cobas Cdiff Test to detect Clostridium difficile (C. difficile) in stool specimens.
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
KalVista Pharmaceuticals, a research-led pharmaceutical company, today announced it has raised $33 million in a Series B financing to support its research and clinical development programs. KalVista will use the funds to advance its proprietary portfolio of plasma kallikrein inhibitors for treating diabetic macular edema (DME) and hereditary angioedema (HAE).
› Verified 2 days ago
News Archive
An outbreak of Dengue Haemorrhagic Fever (DHF) in Delhi, India has authorities concerned that they may be seeing the start of an epidemic.
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
Roche announced today that the US Food and Drug Administration has provided 510(k) clearance for the cobas Cdiff Test to detect Clostridium difficile (C. difficile) in stool specimens.
Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.
KalVista Pharmaceuticals, a research-led pharmaceutical company, today announced it has raised $33 million in a Series B financing to support its research and clinical development programs. KalVista will use the funds to advance its proprietary portfolio of plasma kallikrein inhibitors for treating diabetic macular edema (DME) and hereditary angioedema (HAE).
› Verified 2 days ago
Cvs Pharmacy #16188 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2505 1st St S, Willmar, Minnesota 56201 Phone: (320) 235-3026 | |
Medical Supplies, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 312 4th St Sw, Willmar, Minnesota 56201 Phone: (320) 231-3655 | |
Wal-mart Pharmacy 10-1470 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 700 19th Ave Se, Willmar, Minnesota 56201 Phone: (320) 231-3313 | |
Thrifty White Pharmacy #022 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2300 1st S St, Willmar, Minnesota 56201 Phone: (320) 235-1930 | |
Cub Pharmacy # 1607/704 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2201 1st St S, Willmar, Minnesota 56201 Phone: (320) 214-8502 |